{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T23:04:17Z","timestamp":1770332657390,"version":"3.49.0"},"reference-count":55,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2022,9,17]],"date-time":"2022-09-17T00:00:00Z","timestamp":1663372800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"ISU startup fund"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>Rheumatoid arthritis (RA) is a chronic inflammatory condition of synovial joints that causes disability and systemic complications. Ang-(1-7), one of the main peptides in the renin-angiotensin (Ang) system (RAS), imposes its protective effects through Mas receptor (MasR) signaling. It has a short half-life, limiting its feasibility as a therapeutic agent. In this study, we evaluated the anti-inflammatory effects of Ang-(1-7)\u2019s novel and stable conjugate (Ang. Conj.) by utilizing its affinity for bone through bisphosphonate (BP) moiety in an adjuvant-induced arthritis (AIA) rat model. The rats received subcutaneous injections of vehicle, plain Ang-(1-7), or an equivalent dose of Ang. Conj. The rats\u2019 body weights, paws, and joints\u2019 diameters were measured thrice weekly. After 14 days, the rats were euthanized, and the blood and tissue samples were harvested for further analysis of nitric oxide (NO) and RAS components\u2019 gene and protein expression. The administration of Ang. Conj. reduced body weight loss, joint edema, and serum NO. Moreover, the Ang. Conj. treatment significantly reduced the classical arm components at peptide, enzyme, and receptor levels while augmenting them for the protective arm. The results of this study introduce a novel class of bone-targeting natural peptides for RA caused by an inflammation-induced imbalance in the activated RAS. Our results indicate that extending the half-life of Ang-(1-7) augments the RAS protective arm and exerts enhanced therapeutic effects in the AIA model in rats.<\/jats:p>","DOI":"10.3390\/ph15091157","type":"journal-article","created":{"date-parts":[[2022,9,19]],"date-time":"2022-09-19T04:49:22Z","timestamp":1663562962000},"page":"1157","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Anti-Inflammatory Effects of Ang-(1-7) Bone-Targeting Conjugate in an Adjuvant-Induced Arthritis Rat Model"],"prefix":"10.3390","volume":"15","author":[{"given":"Sana","family":"Khajeh pour","sequence":"first","affiliation":[{"name":"College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9382-9800","authenticated-orcid":false,"given":"Arina","family":"Ranjit","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Summerill","sequence":"additional","affiliation":[{"name":"College of Health, Idaho State University, Pocatello, ID 83209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4456-3123","authenticated-orcid":false,"given":"Ali","family":"Aghazadeh-Habashi","sequence":"additional","affiliation":[{"name":"College of Pharmacy, Idaho State University, Pocatello, ID 83209, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,9,17]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"v3","DOI":"10.1093\/rheumatology\/kes113","article-title":"Understanding the dynamics: Pathways involved in the pathogenesis of rheumatoid arthritis","volume":"51","author":"Choy","year":"2012","journal-title":"Rheumatology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.rdc.2010.02.002","article-title":"Cardiovascular complications of rheumatoid arthritis: Assessment, prevention, and treatment","volume":"36","author":"Kaplan","year":"2010","journal-title":"Rheum. Dis. Clin."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2801","DOI":"10.1007\/s00198-017-4170-5","article-title":"Skeletal complications of rheumatoid arthritis","volume":"28","author":"Heinlen","year":"2017","journal-title":"Osteoporos. Int."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.amjmed.2007.04.005","article-title":"Rheumatoid arthritis: Diagnosis and management","volume":"120","author":"Majithia","year":"2007","journal-title":"Am. J. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s00296-004-0564-8","article-title":"Renin and angiotensin-converting enzyme (ACE) as active components of the local synovial renin-angiotensin system in rheumatoid arthritis","volume":"25","author":"Cobankara","year":"2005","journal-title":"Rheumatol. Int."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1007\/s11033-021-06672-8","article-title":"The role of renin angiotensin system in the pathophysiology of rheumatoid arthritis","volume":"48","author":"Moreira","year":"2021","journal-title":"Mol. Biol. Rep."},{"key":"ref_8","first-page":"1009","article-title":"Mortality trends in rheumatoid arthritis: The role of rheumatoid factor","volume":"35","author":"Gonzalez","year":"2008","journal-title":"J. Rheumatol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.amjmed.2008.06.011","article-title":"Cardiovascular morbidity and mortality in rheumatoid arthritis","volume":"121","author":"Gabriel","year":"2008","journal-title":"Am. J. Med."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/01.bor.0000218951.65601.bf","article-title":"Cardiovascular disease in rheumatoid arthritis","volume":"18","author":"Kaplan","year":"2006","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"H2254","DOI":"10.1152\/ajpheart.00191.2001","article-title":"Differential ANG II generation in plasma and tissue of mice with decreased expression of the ACE gene","volume":"282","author":"Wei","year":"2002","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"5569","DOI":"10.4049\/jimmunol.1000314","article-title":"Anti-inflammatory effects of the activation of the angiotensin-(1\u20137) receptor, MAS, in experimental models of arthritis","volume":"185","author":"Coelho","year":"2010","journal-title":"J. Immunol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1161\/HYPERTENSIONAHA.117.10406","article-title":"Angiotensin-(1\u20137) and vascular function: The clinical context","volume":"71","author":"Touyz","year":"2018","journal-title":"Hypertension"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.3389\/fimmu.2017.01596","article-title":"Angiotensin-(1-7) promotes resolution of neutrophilic inflammation in a model of antigen-induced arthritis in mice","volume":"8","author":"Barroso","year":"2017","journal-title":"Front. Immunol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMra1004965","article-title":"The pathogenesis of rheumatoid arthritis","volume":"365","author":"McInnes","year":"2011","journal-title":"New Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00726-020-02935-z","article-title":"Angiotensin-(1\u20137) attenuates collagen-induced arthritis via inhibiting oxidative stress in rats","volume":"53","author":"Liu","year":"2021","journal-title":"Amino Acids"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0014-2999(94)00672-T","article-title":"Suppression of adjuvant-induced arthritis by selective inhibition of inducible nitric oxide synthase","volume":"273","author":"Connor","year":"1995","journal-title":"Eur. J. Pharmacol."},{"key":"ref_18","first-page":"714","article-title":"Therapeutic administration of a selective inhibitor of nitric oxide synthase does not ameliorate the chronic inflammation and tissue damage associated with adjuvant-induced arthritis in rats","volume":"284","author":"Fletcher","year":"1998","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_19","first-page":"1922","article-title":"Comparison of the nitric oxide synthase inhibitors methylarginine and aminoguanidine as prophylactic and therapeutic agents in rat adjuvant arthritis","volume":"22","author":"Meyers","year":"1995","journal-title":"J. Rheumatol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1084\/jem.178.2.749","article-title":"Suppression of arthritis by an inhibitor of nitric oxide synthase","volume":"178","author":"Allen","year":"1993","journal-title":"J. Exp. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S1089-8603(03)00025-9","article-title":"Association between the expression of inducible nitric oxide synthase by chondrocytes and its nitric oxide-generating activity in adjuvant arthritis in rats","volume":"8","author":"Yonekura","year":"2003","journal-title":"Nitric Oxide"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"482","DOI":"10.3389\/fphar.2016.00482","article-title":"The angiotensin-(1-7)\/mas axis counteracts angiotensin II-dependent and-independent pro-inflammatory signaling in human vascular smooth muscle cells","volume":"7","author":"Villalobos","year":"2016","journal-title":"Front. Pharmacol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1161\/01.HYP.31.1.362","article-title":"Metabolism of angiotensin-(1\u20137) by angiotensin-converting enzyme","volume":"31","author":"Chappell","year":"1998","journal-title":"Hypertension"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1002\/jps.22730","article-title":"Toxicological and toxicokinetic analysis of angiotensin (1\u20137) in two species","volume":"101","author":"Mordwinkin","year":"2012","journal-title":"J. Pharm. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1007\/s00726-021-02972-2","article-title":"Improved pharmacokinetics and bone tissue accumulation of Angiotensin-(1\u20137) peptide through bisphosphonate conjugation","volume":"53","author":"Khajehpour","year":"2021","journal-title":"Amino Acids"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.2165\/00003088-200342150-00002","article-title":"Bone-specific drug delivery systems","volume":"42","author":"Hirabayashi","year":"2003","journal-title":"Clin. Pharmacokinet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1007\/s13346-017-0394-3","article-title":"Bone-seeking agents for the treatment of bone disorders","volume":"7","author":"Cawthray","year":"2017","journal-title":"Drug delivery and translational research"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s13346-017-0407-2","article-title":"Bone-targeting parathyroid hormone conjugates outperform unmodified PTH in the anabolic treatment of osteoporosis in rats","volume":"7","author":"Yang","year":"2017","journal-title":"Drug Deliv. Transl. Res."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/156720181201150310154026","article-title":"Evaluation of bone targeting salmon calcitonin analogues in rats developing osteoporosis and adjuvant arthritis","volume":"12","author":"Bhandari","year":"2015","journal-title":"Curr. Drug Deliv."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1021\/mp8002368","article-title":"Improved bone delivery of osteoprotegerin by bisphosphonate conjugation in a rat model of osteoarthritis","volume":"6","author":"Doschak","year":"2009","journal-title":"Mol. Pharm."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1136\/ard.51.11.1219","article-title":"Increased concentrations of nitrite in synovial fluid and serum samples suggest increased nitric oxide synthesis in rheumatic diseases","volume":"51","author":"Farrell","year":"1992","journal-title":"Ann. Rheum. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1084\/jem.184.4.1519","article-title":"Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients","volume":"184","author":"McInnes","year":"1996","journal-title":"J. Exp. Med."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0014-2999(92)90526-A","article-title":"Modulation of acute inflammation by endogenous nitric oxide","volume":"211","author":"Ialenti","year":"1992","journal-title":"Eur. J. Pharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10787-017-0344-1","article-title":"Cardiovascular effect of inflammation and nonsteroidal anti-inflammatory drugs on renin\u2013angiotensin system in experimental arthritis","volume":"25","author":"Asghar","year":"2017","journal-title":"Inflammopharmacology"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/art.20855","article-title":"Cardiovascular death in rheumatoid arthritis: A population-based study","volume":"52","author":"Nicola","year":"2005","journal-title":"Arthritis Rheum."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/1470320309347785","article-title":"The angiotensin II type 2 receptor in cardiovascular disease","volume":"11","author":"Schiffrin","year":"2010","journal-title":"J. Renin-Angiotensin-Aldosterone Syst."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/00041552-200105000-00005","article-title":"Proinflammatory actions of angiotensins","volume":"10","author":"Lorenzo","year":"2001","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Kortekaas, K.E., Meijer, C.A., Hinnen, J.W., Dalman, R.L., Xu, B., Hamming, J.F., and Lindeman, J.H. (2014). ACE inhibitors potently reduce vascular inflammation, results of an open proof-of-concept study in the abdominal aortic aneurysm. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0111952"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s10571-009-9368-4","article-title":"Anti-inflammatory effects of angiotensin receptor blockers in the brain and the periphery","volume":"29","author":"Benicky","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/hr.2013.3","article-title":"Irbesartan, an angiotensin receptor blocker, exhibits metabolic, anti-inflammatory and antioxidative effects in patients with high-risk hypertension","volume":"36","author":"Taguchi","year":"2013","journal-title":"Hypertens. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1002\/art.22335","article-title":"Angiotensin II type 1 receptor as a novel therapeutic target in rheumatoid arthritis: In vivo analyses in rodent models of arthritis and ex vivo analyses in human inflammatory synovitis","volume":"56","author":"Price","year":"2007","journal-title":"Arthritis Rheum."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.4049\/jimmunol.176.9.5577","article-title":"Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines","volume":"176","author":"Mateo","year":"2006","journal-title":"J. Immunol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1161\/01.CIR.0000148824.93600.F3","article-title":"Angiotensin II induces neutrophil accumulation in vivo through generation and release of CXC chemokines","volume":"110","author":"Nabah","year":"2004","journal-title":"Circulation"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.pharmthera.2008.05.010","article-title":"Angiotensin II: A hormone involved in and contributing to pro-hypertrophic cardiac networks and target of anti-hypertrophic cross-talks","volume":"119","author":"Wenzel","year":"2008","journal-title":"Pharmacol. Ther."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1139\/cjpp-2013-0488","article-title":"Targeting angiotensin-converting enzyme 2 as a new therapeutic target for cardiovascular diseases","volume":"92","author":"Parajuli","year":"2014","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1258\/ebm.2012.012212","article-title":"Cross-talk between inflammation and angiotensin II: Studies based on direct transfection of cardiomyocytes with AT1R and AT2R cDNA","volume":"237","author":"Xianwei","year":"2012","journal-title":"Exp. Biol. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1124\/dmd.104.002360","article-title":"Effect of early phase adjuvant arthritis on hepatic P450 enzymes and pharmacokinetics of verapamil: An alternative approach to the use of an animal model of inflammation for pharmacokinetic studies","volume":"33","author":"Ling","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/jps.23819","article-title":"Glucosamine dose\/concentration-effect correlation in the rat with adjuvant arthritis","volume":"103","author":"Kohan","year":"2014","journal-title":"J. Pharm. Sci."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ab.2007.06.045","article-title":"Simultaneous analysis of angiotensin peptides by LC\u2013MS and LC\u2013MS\/MS: Metabolism by bovine adrenal endothelial cells","volume":"369","author":"Cui","year":"2007","journal-title":"Anal. Biochem."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12974-015-0261-4","article-title":"Brain endogenous angiotensin II receptor type 2 (AT2-R) protects against DOCA\/salt-induced hypertension in female rats","volume":"12","author":"Dai","year":"2015","journal-title":"J. Neuroinflammation"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2119\/molmed.2010.00111","article-title":"Angiotensin-converting enzyme (ACE) 2 overexpression ameliorates glomerular injury in a rat model of diabetic nephropathy: A comparison with ACE inhibition","volume":"17","author":"Liu","year":"2011","journal-title":"Mol. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.lfs.2018.07.013","article-title":"Sini decoction alleviates E. coli induced acute lung injury in mice via equilibrating ACE-AngII-AT1R and ACE2-Ang-(1-7)-Mas axis","volume":"208","author":"Liu","year":"2018","journal-title":"Life Sci."},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Exner, E.C., Geurts, A.M., Hoffmann, B.R., Casati, M., Stodola, T., Dsouza, N.R., Zimmermann, M., Lombard, J.H., and Greene, A.S. (2020). Interaction between Mas1 and AT1RA contributes to enhancement of skeletal muscle angiogenesis by angiotensin-(1-7) in Dahl salt-sensitive rats. PLoS ONE, 15.","DOI":"10.1371\/journal.pone.0232067"},{"key":"ref_54","first-page":"1753","article-title":"Effect of prehypertensive losartan therapy on AT1R and ATRAP methylation of adipose tissue in the later life of high-fat-fed spontaneously hypertensive rats","volume":"17","author":"Wang","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.bjp.0707538","article-title":"Effects of angiotensin II blockade on inflammation-induced alterations of pharmacokinetics and pharmacodynamics of calcium channel blockers","volume":"153","author":"Hanafy","year":"2008","journal-title":"Br. J. Pharmacol."}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/9\/1157\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T00:33:31Z","timestamp":1760142811000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/15\/9\/1157"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,17]]},"references-count":55,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2022,9]]}},"alternative-id":["ph15091157"],"URL":"https:\/\/doi.org\/10.3390\/ph15091157","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,17]]}}}